Abstract
IBD flares or new diagnosis in patients receiving anti-TNF because of other diseases than IBD are rare events but the possibility of a paradoxical reaction must be considered as with psoriasis or uveitis. We present a patient suffering from RA who had a new CD onset after a two-year adalimumab treatment.
MeSH terms
-
Adalimumab
-
Adult
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antirheumatic Agents / adverse effects*
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / complications
-
Arthritis, Rheumatoid / drug therapy*
-
Crohn Disease / chemically induced*
-
Crohn Disease / complications
-
Crohn Disease / diagnosis
-
Female
-
Humans
Substances
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Adalimumab